e Using a Galleria mellonella animal model, we compared the virulence of two sequence type 258 (ST258) KPC-producing Klebsiella pneumoniae strains, which were representative of the two clades of this clonal lineage, with that of isogenic colistin-resistant mgrB mutants. With both strains, the mgrB mutants did not exhibit modification in virulence. In the G. mellonella model, the clade 1 strain (capsular type cps-1 [wzi29, producing KPC-2]) was significantly more virulent than the clade 2 strain (capsular type cps-2 [wzi154, producing KPC-3]).
C
olistin is a backbone component of combination antimicrobial regimens for serious infections caused by carbapenemase-producing strains of Klebsiella pneumoniae (1, 2) , which are among the most challenging antibiotic-resistant pathogens spreading globally (3, 4) . However, in settings in which carbapenemase-producing K. pneumoniae is endemic, the emergence and rapid dissemination of colistin resistance have been reported, especially among KPC carbapenemase-producing K. pneumoniae strains, including those of the pandemic sequence type 258 (ST258) clonal lineage (5) (6) (7) (8) (9) .
Colistin resistance is mostly due to modification of the antibiotic target (the lipid A moiety of the bacterial lipopolysaccharide [LPS] ), which can be mediated by different mutational events upregulating the endogenous LPS modification systems (10) (11) (12) (13) (14) , or by the acquisition of exogenous genes encoding LPS modification systems (15) . Mutations causing a loss of function in the MgrB protein, a negative-feedback regulator of the PhoP-PhoQ signal transduction system, which controls several biochemical pathways, including those involved in LPS modification, are a frequent mechanism of acquired colistin resistance among KPC carbapenemase-producing K. pneumoniae strains circulating in the clinical setting (14, 16, 17) .
We previously showed that colistin resistance associated with inactivation of the mgrB gene is not associated with a significant biological cost and is stably maintained in the absence of selective pressure (18) , a finding consistent with the rapid and efficient dissemination of colistin-resistant (COL r ) KPC carbapenemaseproducing K. pneumoniae strains carrying this resistance mechanism observed in the clinical setting (7, 9) .
In this work, we investigated the impact of colistin resistance, mediated by mgrB inactivation, on the virulence of KPC carbapenemase-producing K. pneumoniae strains representative of the two clades of the pandemic ST258 clonal lineage (19); we used the Galleria mellonella infection model, which is considered to be a validated model for testing the virulence of K. pneumoniae (20, 21) .
The KPC carbapenemase-producing K. pneumoniae strains used in the experiments are described in Table 1 . KK207-1 and KKBO-1 are two previously described strains and are representative of the two clades of ST258 (clades 1 and 2, respectively) (22) . The mgrB insertional mutant of KKBO-1 (named mutKKBO-1) was previously described (18) , while the mgrB mutant of KK207-1 (named mutKK207-1) was obtained with the same approach as for mutKKBO-1 and carried an ISKpn18 insertion disrupting the mgrB gene. The colistin MICs of the strains were determined by reference broth microdilution (23) .
For experiments with G. mellonella, bacteria were grown aerobically in LB broth at 37°C, harvested during exponential phase (optical density at 600 nm [OD 600 ], Ϸ0.7), and washed once with 10 mM phosphate-buffered saline (PBS) (pH 6.5). Bacteria were then suspended in PBS to an OD 600 of 1.5, corresponding to approximately 1 ϫ 10 9 CFU/ml. Larvae weighing 450 to 600 mg were used for the experiments. For a comparative evaluation of virulence, groups of 10 larvae were injected with 5 ϫ 10 5 CFU of each strain and with sterile PBS as a control. The larvae were kept at 37°C in the dark under a humidified atmosphere, with food, and examined daily for pigmentation and mobility. Time of death was recorded at 24, 48, and 72 h. Three independent experiments were performed. The 50% lethal dose (LD 50 ) was determined by inoculating larvae with 10-fold serial dilutions of each strain containing 5 ϫ 10 4 to 5 ϫ 10 7 CFU. Ten larvae were injected with each dilution. For each strain, data from three independent experiments were combined. LD 50 s were calculated using the GraphPad Prism 6.0 software (GraphPad Software, Inc., La Jolla, CA) and were compared using a two-tailed t test. P values of Ͻ0.05 were considered statistically significant. K. pneumoniae NTUH-K2044, an ST23 virulent strain with the K1 capsular serotype (24) , was included in all experiments as a virulent control.
All the studied strains caused a time-dependent death of larvae. In the 5 ϫ 10 5 CFU challenge, KKBO-1 (clade 2) killed, on average, 10% and 17% of larvae at 24 h and 72 h postinfection, respectively. In contrast, KK207-1 (clade 1) caused higher mortality, with average mortality rates of 55% and 65% at 24 h and 72 h, respectively. No differences were seen between the killing rates caused by the colistin-susceptible ST258 strains and the respective mgrB-inactivated COL r mutants (Fig. 1 ). In the experiments with scalar inoculum sizes, all tested strains caused larval mortality in a dose-dependent manner. No significant differences were observed in the LD 50 s of KKBO-1 (colistin susceptible [COL s ]) versus mutKKBO-1 (COL r ) (P ϭ 0.13), and of KK207-1 (COL s ) versus mutKK207-1 (COL r ) (P ϭ 0.51). On the other hand, the LD 50 s of KK207-1 and mutKK207-1 (clade 1) were significantly lower than those of KKBO-1 and mutKKBO-1 (clade 2) (P Ͻ 0.05) ( Table 1) .
The COL r phenotype was checked in isolates obtained from larvae infected with mutKKBO-1 and mutKK207-1 at 24 and 72 h postinfection (60 isolates per experiment) and was confirmed in all tested isolates, revealing stability after the in vivo passage.
Altogether, the results of these experiments indicated that the emergence of colistin resistance mediated by inactivation of the mgrB gene is apparently not associated with significant modifications to the virulence potential of KPC carbapenemase-producing K. pneumoniae representative of the two clades of the ST258 clonal lineage. This finding is notably different from what was observed with COL r mutants of Acinetobacter baumannii, which exhibit a remarkable impairment of virulence potential (25) (26) (27) , and it is consistent with the observation that COL r KPC carbapenemase-producing K. pneumoniae strains of clonal complex 258 (CC258) are capable of causing severe invasive infections and large outbreaks (8, 9) , similar to their colistin-susceptible counterparts. In fact, recent clinical studies have reported that mortality rates among patients with infections caused by COL r KPC carbapenemaseproducing K. pneumoniae strains were higher than those among patients infected by colistin-susceptible KPC carbapenemaseproducing K. pneumoniae strains (8, 28) . The present results suggest that this reported mortality rate excess is likely attributable to the further narrowing of available therapeutic options rather than to an increased virulence potential of COL r KPC carbapenemase-producing K. pneumoniae strains.
Our data also confirmed previous findings that ST258 strains of clade 2 (with a cps-2 capsular gene cluster) exhibit an overall low virulence potential in the G. mellonella model (29) compared with that of highly virulent K. pneumoniae strains, such as NTUH-K2044. On the other hand, for the ST258 strain of clade 1 (with a cps-1 capsular gene cluster), we documented a higher virulence potential than that for clade 2 strains, which was similar to that of NTUH-K2044. This finding apparently differs from that of a previous study that reported a low virulence potential for a KPC-2-producing ST258 strain of clade 1 (deduced by the K41 serotype) in a mouse septicemia model (30) . Further studies will be necessary to confirm these discrepancies, which might be dependent on strain-specific differences and/or differences in the animal infection models and their immune systems. In fact, G. mellonella moths lack an adaptive immune response, and the model can be used only to approximate mammals' innate immune response to bacterial infections. However, the difference in virulence among the clade 1 and clade 2 strains observed in this work is consistent with the different prevalences observed for the two clades, with an overall predominance of clade 2 strains in settings of high-level endemicity of KPC carbapenemase-producing K. pneumoniae strains of CC258 (22, 29) .
In conclusion, our findings suggest that COL r KPC carbapenemase-producing K. pneumoniae strains of ST258 carrying an in- activated mgrB gene might be as virulent as their COL s ancestors. Efforts focused at containing their dissemination should therefore be maximized. Our findings also suggest that significant differences might exist in the interaction of ST258 strains of KPC carbapenemase-producing K. pneumoniae of clades 1 and 2 with the innate immune response, regardless of their colistin susceptibility status.
